Yale Cancer Center

https://www.yalecancercenter.org/

 

Insights from 2025 Tandem Annual Meeting
I

Tandem 2025 Insights: Effectiveness and Safety Outcomes of SoC Liso-Cel in R/R Transformed LBCL - Results From CIBMTR Registry

By Insights from 2025 Tandem Annual Meeting FEATURING Iris Isufi
By Insights from 2025 Tandem Annual Meeting FEATURING Iris Isufi
1 view
March 20, 2025
Comments 0
Login to view comments. Click here to Login

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Hematologic Oncology
11:05

New

Tandem 2025 Insights: Effectiveness and Safety Outcomes of SoC Liso-…

Insights from 2025 Tandem Annual Meeting

I. Isufi

09:38

New

Pivotal Ph2 MonumenTAL-1 Trial: Evaluating the Efficacy & Safety of …

Yale Cancer Center

N. Neparidze

11 views
04:14

ASH 2024 Insights: E1910 Update - Addition of Blinatumomab to Consol…

2024 ASH Annual Meeting Insights Hub

N. Podoltsev

80 views
10:07

FDA Approval of E7777 (Denileukin Diftitox) for R/R CTCL - Summary o…

Yale Cancer Center

F. Foss

310 views
27:25

The Role of Radiation in Patients Undergoing CAR T-Cell Therapy for …

Yale Cancer Center

T. Robinson

8 views
09:31

The Role of Hypomethylating Agent Maintenance in AML

Yale Cancer Center

R. Shallis

121 views
09:39

Retreating vs. Switching: Deciding on Next Steps for Patients With M…

Yale Cancer Center

S. Kothari

103 views
31:13

Selected Updates in MDS

ASH 2022 Conference Coverage

A. Zeidan

491 views
48

Lecture Summary - The Importance of the TP53 Evaluation in the Manag…

Yale Cancer Center

R. Shallis

23 views
15:31

The Importance of the TP53 Evaluation in the Management of HR-MDS

Yale Cancer Center

R. Shallis

53 views
15:31
Yale Cancer Center

[private] Lecture Summary - The Importance of the TP53 Evaluation in…

Feat. R. Shallis
07:27

ASCO 2021 Highlights on Treatment-Naïve Higher-Risk MDS: CR/OS Data …

Yale Cancer Center

A. Zeidan

68 views
11:10

Yale Cancer Center Multiple Myeloma and Gammopathies: Translational …

Yale Cancer Center

N. Neparidze

131 views
14:23

Translational Science in Myeloid Malignancies at Yale: Immunologic A…

Yale Cancer Center

T. Prebet

24:06

Post-Transplant Lymphoproliferative Disorders: WHO Classification, E…

Yale Cancer Center

F. Montanari

79 views
25:06

Mechanisms of B-Cell Selection as Therapeutic Targets in Leukemia an…

Yale Cancer Center

M. Muschen

16:29

B-Cell Selection as Therapeutic Targets in Leukemia and Lymphoma: Ta…

Yale Cancer Center

M. Muschen

15:10

First Randomized Trial of Azacitidine w/ Durvalumab for the Front-Li…

Yale Cancer Center

A. Zeidan

374 views
14:39

Safety, Efficacy, and Biomarker Analysis of a Phase 1 Study of PLK1 …

Yale Cancer Center

A. Zeidan

102 views
12:32

Safety and Efficacy of a Phase 1b Study of Venetoclax Monotherapy or…

Yale Cancer Center

A. Zeidan

109 views